A major shift in how the NHS delivers care could transform the future of medical research across Britain, potentially opening doors to more representative studies whilst creating new challenges for innovation funding and infrastructure.
The National Health Service's strategic move to provide more care in community settings—rather than primarily in hospitals—presents both promising opportunities and significant hurdles for medical research, according to analysis by The King's Fund.
Traditionally, most UK medical research has taken place in large hospitals and academic medical centres. These institutions have the specialist equipment, dedicated research teams, and high patient numbers needed for complex clinical trials. But as the NHS increasingly focuses on managing long-term conditions, preventative care, and rehabilitation closer to patients' homes, researchers may need to adapt where and how they conduct studies.
This shift could open research to a much more diverse group of patients. Community settings like GP surgeries, local health centres, and even people's homes could make it easier for those who struggle to reach hospitals—including rural residents, older adults, and people with mobility problems—to participate in studies. This could lead to research findings that better reflect the entire UK population, ultimately making new treatments more effective for everyone.
However, The King's Fund report identifies several significant challenges. Research funding, which typically flows through established hospital trusts, may need restructuring to adequately support community-based initiatives. Building the necessary research infrastructure—including trained staff, data management systems, and regulatory compliance—across numerous smaller community organisations will require substantial investment and careful planning. Maintaining consistent quality across diverse community research sites will also be crucial.
Health inequalities present another key consideration. If research remains concentrated in hospitals, communities with poor access to these facilities may miss out on cutting-edge treatments and trials. However, a well-managed shift could enable research to better address specific health needs in underserved areas, potentially reducing health inequalities across the UK.
The success of integrating research into community care will ultimately depend on coordinated efforts from policymakers, NHS leaders, researchers, and patient groups working together to navigate this complex transition.